WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?

Insider buying vs selling

Have Inmed Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alexandra Diane Janet ManciniInsider2024-07-31240$0.18
$42.24Sell
Andrew HullDirector2024-02-2137,500$0.39
$14.63kBuy
Eric A. AdamsPresident CEO2024-02-2041,600$0.36
$14.93kBuy

1 of 1

INM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INM insiders and whales buy or sell their stock.

INM Shareholders

What type of owners hold Inmed Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Shane Aaron Johnson4.37%583,023$131.76kInsider
Sabby Management LLC2.30%307,236$69.44kInstitution
Virtu Financial LLC0.65%86,684$19.59kInstitution
Eric A. Adams0.33%43,959$9.93kInsider
Andrew Hull0.29%38,258$8.65kInsider
Xtx Topco Ltd0.13%17,819$4.03kInstitution
Hrt Financial LP0.12%15,996$3.62kInstitution
Citadel Advisors LLC0.09%12,097$2.73kInstitution
Bruce Colwill0.09%11,515$2.60kInsider
Qube Research Technologies Ltd0.00%200$45.20Institution

1 of 2

INM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INM3.30%5.07%Net Buying
ENTO2.55%97.45%Net SellingNet Selling
PBM2.26%22.20%
TNXP1.49%70.58%
TNFA0.84%99.16%

Inmed Pharmaceuticals Stock Ownership FAQ

Who owns Inmed Pharmaceuticals?

Inmed Pharmaceuticals (NASDAQ: INM) is owned by 3.30% institutional shareholders, 5.07% Inmed Pharmaceuticals insiders, and 91.63% retail investors. Shane Aaron Johnson is the largest individual Inmed Pharmaceuticals shareholder, owning 583,023.00 shares representing 4.37% of the company. Shane Aaron Johnson's Inmed Pharmaceuticals shares are currently valued at $137.01k.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.